HIGHLIGHTS
- who: Sarah Goldman-Mazur from the (UNIVERSITY) have published the article: Second- and third-line treatment strategies in multiple myeloma: a referral-center experience, in the Journal: (JOURNAL) of 24/08/2022
- what: Next, the authors aimed to show if the effectiveness of second-line therapies (reflected by post-progression survivals) has improved over time and the impact of specific regimens. To visualize trends in treatment choices, the authors divided the study period into nine 2-year intervals, and for descriptive purposes, the period was divided into three 6-year intervals. The study shows continued . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.